Vai direttamente al contenuto

Ostetricia

Gestione della trombocitopenia

Rescue therapy with romiplostim for refractory primary immune thrombocytopenia during pregnancy. (apre una nuova finestra)

Decroocq J, Marcellin L, Le Ray C, Willems L.

Fonte‎: Obstet Gynecol 2014;124(2 Pt 2 Suppl 1):481-3.

Indicizzato‎: PubMed 25004319

DOI‎: 10.1097/AOG.0000000000000371

https://www.ncbi.nlm.nih.gov/pubmed/25004319 (apre una nuova finestra)

Use of thrombopoietin receptor agonists for immune thrombocytopenia in pregnancy: results from a multicenter study. (apre una nuova finestra)

Michel M, Ruggeri M, Gonzalez-Lopez TJ, Alkindi SS, Cheze S, Ghanima W, Tvedt THA, Ebbo M, Terriou L, Bussel JB, Godeau B

Fonte‎: Blood 2020;136(26):3056-61.

Indicizzato‎: PubMed 32814348

DOI‎: 10.1182/blood.2020007594

https://www.ncbi.nlm.nih.gov/pubmed/32814348 (apre una nuova finestra)

A case of refractory immune thrombocytopenia in pregnancy managed with elthrombopag. (apre una nuova finestra)

Purushothaman J, Puthumana KJ, Kumar A, Innah SJ, Gilvaz S.

Fonte‎: Asian J Transfus Sci 2016;10(2):155-8.

Indicizzato‎: PubMed 27605856

DOI‎: 10.4103/0973-6247.177204

https://www.ncbi.nlm.nih.gov/pubmed/27605856 (apre una nuova finestra)

Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study. (apre una nuova finestra)

Saleh MN, Bussel JB, Cheng G, Meyer O, Bailey CK, Arning M, Brainsky A; EXTEND Study Group.

Fonte‎: Blood 2013;121(3):537-45.

Indicizzato‎: PubMed 23169778

https://www.ncbi.nlm.nih.gov/pubmed/23169778 (apre una nuova finestra)